DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers
Identification of early changes in Dopamine-Transporter (DaT) SPECT imaging expected in the prodromal phase of Parkinson's disease (PD), are usually overlooked. Carriers of the G2019S LRRK2 mutation are known to be at high risk for developing PD, compared to non-carriers. In this work we aimed...
Saved in:
| Published in | PloS one Vol. 12; no. 4; p. e0175424 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
13.04.2017
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Identification of early changes in Dopamine-Transporter (DaT) SPECT imaging expected in the prodromal phase of Parkinson's disease (PD), are usually overlooked. Carriers of the G2019S LRRK2 mutation are known to be at high risk for developing PD, compared to non-carriers. In this work we aimed to study early changes in Dopamine uptake in non-manifesting PD carriers (NMC) of the G2019S LRRK2 mutation using quantitative DaT-SPECT analysis and to examine the potential for early prediction of PD. Eighty Ashkenazi-Jewish subjects were included in this study: eighteen patients with PD; thirty-one NMC and thirty-one non-manifesting non-carriers (NMNC). All subjects underwent a through clinical assessment including evaluation of motor, olfactory, affective and non-motor symptoms and DaT-SPECT imaging. A population based DaT-SPECT template was created based on the NMNC cohort, and data driven volumes-of-interest (VOIs) were defined. Comparisons between groups were performed based on VOIs and voxel-wise analysis. The striatum area of all three cohorts was segmented into four VOIs, corresponding to the right/left dorsal and ventral striatum. Significant differences in clinical measures were found between patients with PD and non-manifesting subjects with no differences between NMC and NMNC. Significantly lower uptake (p<0.001) was detected in the right and left dorsal striatum in the PD group (2.2±0.3, 2.3±0.4) compared to the NMC (4.2±0.6, 4.3±0.5) and NMNC (4.5±0.6, 4.6±0.6), and significantly (p = 0.05) lower uptake in the right dorsal striatum in the NMC group compared to NMNC. Converging results were obtained using voxel-wise analysis. Two NMC participants, who later phenoconverted into PD, demonstrated reduced uptake mainly in the dorsal striatum. No significant correlations were found between the DaT-SPECT uptake in the different VOIs and clinical and behavioral assessments in the non-manifesting groups. This study shows the clinical value of quantitative assessment of DaT-SPECT imaging and the potential for predicting PD by detection of dopamine depletion, already at the pre-symptomatic stage. Clinical registration numbers: NCT01089270 and NCT01089283. |
|---|---|
| AbstractList | Identification of early changes in Dopamine-Transporter (DaT) SPECT imaging expected in the prodromal phase of Parkinson’s disease (PD), are usually overlooked. Carriers of the G2019S
LRRK2
mutation are known to be at high risk for developing PD, compared to non-carriers. In this work we aimed to study early changes in Dopamine uptake in non-manifesting PD carriers (NMC) of the G2019S
LRRK2
mutation using quantitative DaT-SPECT analysis and to examine the potential for early prediction of PD. Eighty Ashkenazi-Jewish subjects were included in this study: eighteen patients with PD; thirty-one NMC and thirty-one non-manifesting non-carriers (NMNC). All subjects underwent a through clinical assessment including evaluation of motor, olfactory, affective and non-motor symptoms and DaT-SPECT imaging. A population based DaT-SPECT template was created based on the NMNC cohort, and data driven volumes-of-interest (VOIs) were defined. Comparisons between groups were performed based on VOIs and voxel-wise analysis. The striatum area of all three cohorts was segmented into four VOIs, corresponding to the right/left dorsal and ventral striatum. Significant differences in clinical measures were found between patients with PD and non-manifesting subjects with no differences between NMC and NMNC. Significantly lower uptake (
p
<0.001) was detected in the right and left dorsal striatum in the PD group (2.2±0.3, 2.3±0.4) compared to the NMC (4.2±0.6, 4.3±0.5) and NMNC (4.5±0.6, 4.6±0.6), and significantly (
p
= 0.05) lower uptake in the right dorsal striatum in the NMC group compared to NMNC. Converging results were obtained using voxel-wise analysis. Two NMC participants, who later phenoconverted into PD, demonstrated reduced uptake mainly in the dorsal striatum. No significant correlations were found between the DaT-SPECT uptake in the different VOIs and clinical and behavioral assessments in the non-manifesting groups. This study shows the clinical value of quantitative assessment of DaT-SPECT imaging and the potential for predicting PD by detection of dopamine depletion, already at the pre-symptomatic stage.
Clinical registration numbers
:
NCT01089270
and
NCT01089283
. Identification of early changes in Dopamine-Transporter (DaT) SPECT imaging expected in the prodromal phase of Parkinson's disease (PD), are usually overlooked. Carriers of the G2019S LRRK2 mutation are known to be at high risk for developing PD, compared to non-carriers. In this work we aimed to study early changes in Dopamine uptake in non-manifesting PD carriers (NMC) of the G2019S LRRK2 mutation using quantitative DaT-SPECT analysis and to examine the potential for early prediction of PD. Eighty Ashkenazi-Jewish subjects were included in this study: eighteen patients with PD; thirty-one NMC and thirty-one non-manifesting non-carriers (NMNC). All subjects underwent a through clinical assessment including evaluation of motor, olfactory, affective and non-motor symptoms and DaT-SPECT imaging. A population based DaT-SPECT template was created based on the NMNC cohort, and data driven volumes-of-interest (VOIs) were defined. Comparisons between groups were performed based on VOIs and voxel-wise analysis. The striatum area of all three cohorts was segmented into four VOIs, corresponding to the right/left dorsal and ventral striatum. Significant differences in clinical measures were found between patients with PD and non-manifesting subjects with no differences between NMC and NMNC. Significantly lower uptake (p<0.001) was detected in the right and left dorsal striatum in the PD group (2.2±0.3, 2.3±0.4) compared to the NMC (4.2±0.6, 4.3±0.5) and NMNC (4.5±0.6, 4.6±0.6), and significantly (p = 0.05) lower uptake in the right dorsal striatum in the NMC group compared to NMNC. Converging results were obtained using voxel-wise analysis. Two NMC participants, who later phenoconverted into PD, demonstrated reduced uptake mainly in the dorsal striatum. No significant correlations were found between the DaT-SPECT uptake in the different VOIs and clinical and behavioral assessments in the non-manifesting groups. This study shows the clinical value of quantitative assessment of DaT-SPECT imaging and the potential for predicting PD by detection of dopamine depletion, already at the pre-symptomatic stage. Clinical registration numbers: NCT01089270 and NCT01089283. Identification of early changes in Dopamine-Transporter (DaT) SPECT imaging expected in the prodromal phase of Parkinson's disease (PD), are usually overlooked. Carriers of the G2019S LRRK2 mutation are known to be at high risk for developing PD, compared to non-carriers. In this work we aimed to study early changes in Dopamine uptake in non-manifesting PD carriers (NMC) of the G2019S LRRK2 mutation using quantitative DaT-SPECT analysis and to examine the potential for early prediction of PD. Eighty Ashkenazi-Jewish subjects were included in this study: eighteen patients with PD; thirty-one NMC and thirty-one non-manifesting non-carriers (NMNC). All subjects underwent a through clinical assessment including evaluation of motor, olfactory, affective and non-motor symptoms and DaT-SPECT imaging. A population based DaT-SPECT template was created based on the NMNC cohort, and data driven volumes-of-interest (VOIs) were defined. Comparisons between groups were performed based on VOIs and voxel-wise analysis. The striatum area of all three cohorts was segmented into four VOIs, corresponding to the right/left dorsal and ventral striatum. Significant differences in clinical measures were found between patients with PD and non-manifesting subjects with no differences between NMC and NMNC. Significantly lower uptake (p<0.001) was detected in the right and left dorsal striatum in the PD group (2.2±0.3, 2.3±0.4) compared to the NMC (4.2±0.6, 4.3±0.5) and NMNC (4.5±0.6, 4.6±0.6), and significantly (p = 0.05) lower uptake in the right dorsal striatum in the NMC group compared to NMNC. Converging results were obtained using voxel-wise analysis. Two NMC participants, who later phenoconverted into PD, demonstrated reduced uptake mainly in the dorsal striatum. No significant correlations were found between the DaT-SPECT uptake in the different VOIs and clinical and behavioral assessments in the non-manifesting groups. This study shows the clinical value of quantitative assessment of DaT-SPECT imaging and the potential for predicting PD by detection of dopamine depletion, already at the pre-symptomatic stage. Clinical registration numbers: NCT01089270 and NCT01089283.Identification of early changes in Dopamine-Transporter (DaT) SPECT imaging expected in the prodromal phase of Parkinson's disease (PD), are usually overlooked. Carriers of the G2019S LRRK2 mutation are known to be at high risk for developing PD, compared to non-carriers. In this work we aimed to study early changes in Dopamine uptake in non-manifesting PD carriers (NMC) of the G2019S LRRK2 mutation using quantitative DaT-SPECT analysis and to examine the potential for early prediction of PD. Eighty Ashkenazi-Jewish subjects were included in this study: eighteen patients with PD; thirty-one NMC and thirty-one non-manifesting non-carriers (NMNC). All subjects underwent a through clinical assessment including evaluation of motor, olfactory, affective and non-motor symptoms and DaT-SPECT imaging. A population based DaT-SPECT template was created based on the NMNC cohort, and data driven volumes-of-interest (VOIs) were defined. Comparisons between groups were performed based on VOIs and voxel-wise analysis. The striatum area of all three cohorts was segmented into four VOIs, corresponding to the right/left dorsal and ventral striatum. Significant differences in clinical measures were found between patients with PD and non-manifesting subjects with no differences between NMC and NMNC. Significantly lower uptake (p<0.001) was detected in the right and left dorsal striatum in the PD group (2.2±0.3, 2.3±0.4) compared to the NMC (4.2±0.6, 4.3±0.5) and NMNC (4.5±0.6, 4.6±0.6), and significantly (p = 0.05) lower uptake in the right dorsal striatum in the NMC group compared to NMNC. Converging results were obtained using voxel-wise analysis. Two NMC participants, who later phenoconverted into PD, demonstrated reduced uptake mainly in the dorsal striatum. No significant correlations were found between the DaT-SPECT uptake in the different VOIs and clinical and behavioral assessments in the non-manifesting groups. This study shows the clinical value of quantitative assessment of DaT-SPECT imaging and the potential for predicting PD by detection of dopamine depletion, already at the pre-symptomatic stage. Clinical registration numbers: NCT01089270 and NCT01089283. Identification of early changes in Dopamine-Transporter (DaT) SPECT imaging expected in the prodromal phase of Parkinson's disease (PD), are usually overlooked. Carriers of the G2019S LRRK2 mutation are known to be at high risk for developing PD, compared to non-carriers. In this work we aimed to study early changes in Dopamine uptake in non-manifesting PD carriers (NMC) of the G2019S LRRK2 mutation using quantitative DaT-SPECT analysis and to examine the potential for early prediction of PD. Eighty Ashkenazi-Jewish subjects were included in this study: eighteen patients with PD; thirty-one NMC and thirty-one non-manifesting non-carriers (NMNC). All subjects underwent a through clinical assessment including evaluation of motor, olfactory, affective and non-motor symptoms and DaT-SPECT imaging. A population based DaT-SPECT template was created based on the NMNC cohort, and data driven volumes-of-interest (VOIs) were defined. Comparisons between groups were performed based on VOIs and voxel-wise analysis. The striatum area of all three cohorts was segmented into four VOIs, corresponding to the right/left dorsal and ventral striatum. Significant differences in clinical measures were found between patients with PD and non-manifesting subjects with no differences between NMC and NMNC. Significantly lower uptake (p<0.001) was detected in the right and left dorsal striatum in the PD group (2.2±0.3, 2.3±0.4) compared to the NMC (4.2±0.6, 4.3±0.5) and NMNC (4.5±0.6, 4.6±0.6), and significantly (p = 0.05) lower uptake in the right dorsal striatum in the NMC group compared to NMNC. Converging results were obtained using voxel-wise analysis. Two NMC participants, who later phenoconverted into PD, demonstrated reduced uptake mainly in the dorsal striatum. No significant correlations were found between the DaT-SPECT uptake in the different VOIs and clinical and behavioral assessments in the non-manifesting groups. This study shows the clinical value of quantitative assessment of DaT-SPECT imaging and the potential for predicting PD by detection of dopamine depletion, already at the pre-symptomatic stage. Identification of early changes in Dopamine-Transporter (DaT) SPECT imaging expected in the prodromal phase of Parkinson’s disease (PD), are usually overlooked. Carriers of the G2019S LRRK2 mutation are known to be at high risk for developing PD, compared to non-carriers. In this work we aimed to study early changes in Dopamine uptake in non-manifesting PD carriers (NMC) of the G2019S LRRK2 mutation using quantitative DaT-SPECT analysis and to examine the potential for early prediction of PD. Eighty Ashkenazi-Jewish subjects were included in this study: eighteen patients with PD; thirty-one NMC and thirty-one non-manifesting non-carriers (NMNC). All subjects underwent a through clinical assessment including evaluation of motor, olfactory, affective and non-motor symptoms and DaT-SPECT imaging. A population based DaT-SPECT template was created based on the NMNC cohort, and data driven volumes-of-interest (VOIs) were defined. Comparisons between groups were performed based on VOIs and voxel-wise analysis. The striatum area of all three cohorts was segmented into four VOIs, corresponding to the right/left dorsal and ventral striatum. Significant differences in clinical measures were found between patients with PD and non-manifesting subjects with no differences between NMC and NMNC. Significantly lower uptake (p<0.001) was detected in the right and left dorsal striatum in the PD group (2.2±0.3, 2.3±0.4) compared to the NMC (4.2±0.6, 4.3±0.5) and NMNC (4.5±0.6, 4.6±0.6), and significantly (p = 0.05) lower uptake in the right dorsal striatum in the NMC group compared to NMNC. Converging results were obtained using voxel-wise analysis. Two NMC participants, who later phenoconverted into PD, demonstrated reduced uptake mainly in the dorsal striatum. No significant correlations were found between the DaT-SPECT uptake in the different VOIs and clinical and behavioral assessments in the non-manifesting groups. This study shows the clinical value of quantitative assessment of DaT-SPECT imaging and the potential for predicting PD by detection of dopamine depletion, already at the pre-symptomatic stage. Clinical registration numbers: NCT01089270 and NCT01089283. |
| Audience | Academic |
| Author | Hendler, Talma Lerman Shacham, Hedva Giladi, Nir Urterger, Avi Orr Artzi, Moran Marder, Karen Thaler, Avner Ben Bashat, Dafna Even-Sapir, Einat Mirelman, Anat Bressman, Susan |
| AuthorAffiliation | 4 Movement Disorders Unit, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 2 Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel 7 Mount Sinai-Beth Israel Medical Center, New York, New York, United States of America 6 Columbia University, Columbia University Medical Center, New-York, New York, United States of America 9 Department of Psychology, Tel Aviv University, Tel Aviv, Israel 10 Laboratory for Early Markers of Neurodegenertion, Neurology Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 3 Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel 5 Genetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel Universita degli Studi di Padova, ITALY 1 Functional Brain Center, The Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 8 Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel |
| AuthorAffiliation_xml | – name: 6 Columbia University, Columbia University Medical Center, New-York, New York, United States of America – name: 4 Movement Disorders Unit, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel – name: 1 Functional Brain Center, The Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel – name: 2 Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel – name: 7 Mount Sinai-Beth Israel Medical Center, New York, New York, United States of America – name: Universita degli Studi di Padova, ITALY – name: 8 Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel – name: 10 Laboratory for Early Markers of Neurodegenertion, Neurology Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel – name: 3 Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel – name: 5 Genetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel – name: 9 Department of Psychology, Tel Aviv University, Tel Aviv, Israel |
| Author_xml | – sequence: 1 givenname: Moran surname: Artzi fullname: Artzi, Moran – sequence: 2 givenname: Einat surname: Even-Sapir fullname: Even-Sapir, Einat – sequence: 3 givenname: Hedva surname: Lerman Shacham fullname: Lerman Shacham, Hedva – sequence: 4 givenname: Avner surname: Thaler fullname: Thaler, Avner – sequence: 5 givenname: Avi Orr surname: Urterger fullname: Urterger, Avi Orr – sequence: 6 givenname: Susan surname: Bressman fullname: Bressman, Susan – sequence: 7 givenname: Karen surname: Marder fullname: Marder, Karen – sequence: 8 givenname: Talma surname: Hendler fullname: Hendler, Talma – sequence: 9 givenname: Nir surname: Giladi fullname: Giladi, Nir – sequence: 10 givenname: Dafna orcidid: 0000-0001-8396-1031 surname: Ben Bashat fullname: Ben Bashat, Dafna – sequence: 11 givenname: Anat surname: Mirelman fullname: Mirelman, Anat |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28406934$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk1Fv0zAQxyM0xLbCN0AQCQnBQ4udOK7NA9JUxqioNNQWXq2LY7eekjjYCWLfHqftpmaaEMqDo39-d5f7--48OqltraLoJUYTnE7xhxvbuRrKSRPkCcLTjCTkSXSGeZqMaYLSk6P30-jc-xuEspRR-iw6TRhBlKfkLILPsB6vvl_O1jF4r7yvVN3GhWqMbH1c2AYqU6teKFVrbB1DZetNYG-rprUVtEbGVwnCfBUvlstvSVx1LexACc4Z5fzz6KmG0qsXh3MU_fhyuZ59HS-ur-azi8VYUp6047zQPM00ZpLQghGZgASucs1JTiGFjBAsGVYkTwqCgpRxqgBAIZ5iXWiWjqLX-7xNab04uOMFZmyaTkmWkUDM90Rh4UY0zlTgboUFI3aCdRsBLjRUKgG5pCjhmQatiSwQk4jkJEGKZ6E-6at9OlTr8koVMrjmoBwkHX6pzVZs7G-RpRyjcCWj6N0hgbO_OuVbURkvVVlCrWy3-29GGcaIBvTNA_Tx7g7UBkIDptY21JV9UnFBGM8wp7wvO3mECk-hKiPDKGkT9EHA-0FAYFr1p91A572Yr5b_z17_HLJvj9itgrLdelt2_ez4Ifjq2Ol7i-9mOABkD0hnvXdK3yMYiX5V7uwS_aqIw6qEsI8PwqTZj25wxJT_Dv4L-KkZuQ |
| CitedBy_id | crossref_primary_10_1038_s41531_022_00285_z crossref_primary_10_3390_genes12071006 crossref_primary_10_1111_cns_13933 crossref_primary_10_1590_0100_3984_2020_0087 crossref_primary_10_1007_s11682_018_9920_2 crossref_primary_10_2139_ssrn_4094846 crossref_primary_10_1002_mds_29253 crossref_primary_10_3390_brainsci13081212 crossref_primary_10_1016_j_jns_2018_05_013 crossref_primary_10_1016_j_tins_2021_12_002 crossref_primary_10_1038_s41531_022_00405_9 crossref_primary_10_3389_fnhum_2019_00306 crossref_primary_10_1038_s41467_019_08858_y crossref_primary_10_1016_S1474_4422_19_30319_9 crossref_primary_10_3233_JPD_202337 crossref_primary_10_1038_s41531_022_00404_w crossref_primary_10_1186_s40478_021_01283_7 crossref_primary_10_1038_s41531_024_00854_4 crossref_primary_10_1016_j_ejmech_2023_115475 crossref_primary_10_3390_ijms222011234 crossref_primary_10_1016_j_jocn_2023_01_015 crossref_primary_10_3389_fneur_2020_00395 |
| Cites_doi | 10.2967/jnumed.106.037432 10.1212/01.wnl.0000239829.33936.73 10.1136/jmg.2005.035568 10.1002/mds.10473 10.1002/mds.20844 10.1212/WNL.0b013e31828250d6 10.2967/jnumed.108.059998 10.1136/jnnp.55.3.181 10.1007/978-3-319-00846-2_110 10.1111/j.1532-5415.2005.53221.x 10.1001/jamaneurol.2014.1909 10.1016/j.parkreldis.2011.10.009 10.1212/WNL.0000000000001708 10.1212/01.WNL.0000140706.52798.BE 10.1001/jama.2014.3654 10.1136/jnnp.59.6.597 10.1016/j.neurol.2012.07.004 10.1212/01.wnl.0000338632.00552.cb 10.1016/j.neulet.2005.10.083 10.1002/mds.23019 10.1016/S1353-8020(13)70042-7 10.1016/j.neuroimage.2004.07.051 10.1002/mds.23807 10.1097/RLU.0000000000000766 10.1056/NEJMc055509 10.1002/mds.23965 10.1093/brain/114.5.2283 10.1002/mds.20153 10.1002/mds.21740 10.1002/mds.26478 10.1111/j.1365-2869.2007.00570.x 10.14802/jmd.15003 10.1001/archneur.62.3.353 10.1086/429256 10.1093/brain/awh607 10.1007/s00702-009-0303-0 10.2967/jnumed.106.038646 10.1002/mds.25827 10.1016/j.nbd.2010.05.006 10.1002/mds.26431 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2017 Public Library of Science 2017 Artzi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2017 Artzi et al 2017 Artzi et al |
| Copyright_xml | – notice: COPYRIGHT 2017 Public Library of Science – notice: 2017 Artzi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2017 Artzi et al 2017 Artzi et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0175424 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials - QC Biological Science Collection ProQuest Central ProQuest Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Agricultural Science Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Medicine Psychology Engineering |
| DocumentTitleAlternate | DaT-SPECT among asymptomatic G2019S LRRK2 mutation carriers |
| EISSN | 1932-6203 |
| ExternalDocumentID | 1887374554 oai_doaj_org_article_abc60295faff4cd08c04b420e952d448 PMC5391020 A489519690 28406934 10_1371_journal_pone_0175424 |
| Genre | Clinical Trial Journal Article Comparative Study |
| GeographicLocations | New York Israel Tel Aviv Israel United States--US |
| GeographicLocations_xml | – name: Israel – name: New York – name: Tel Aviv Israel – name: United States--US |
| GrantInformation_xml | – fundername: ; grantid: VIDI grant no. 016.076.352 to B.R.B |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM 3V. BBORY CGR CUY CVF ECM EIF IPNFZ NPM RIG PMFND 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 5PM PUEGO AAPBV ABPTK ESTFP |
| ID | FETCH-LOGICAL-c692t-bdf935f18c46d84c2aca9ebf94b6a3a5441c81e4b2d40b6a596eaaae0931fdf83 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Sun Nov 05 00:20:42 EDT 2023 Wed Aug 27 01:05:05 EDT 2025 Thu Aug 21 17:50:28 EDT 2025 Fri Jul 11 02:57:41 EDT 2025 Fri Jul 25 10:36:00 EDT 2025 Tue Jun 17 21:31:15 EDT 2025 Tue Jun 10 20:34:00 EDT 2025 Fri Jun 27 04:10:47 EDT 2025 Fri Jun 27 04:05:58 EDT 2025 Thu May 22 21:04:15 EDT 2025 Wed Feb 19 02:32:31 EST 2025 Tue Jul 01 03:51:53 EDT 2025 Thu Apr 24 22:55:58 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c692t-bdf935f18c46d84c2aca9ebf94b6a3a5441c81e4b2d40b6a596eaaae0931fdf83 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 Competing Interests: The authors have declared that no competing interests exist. Conceptualization: EES TH AOU NG DBB AM.Data curation: EES HL AT AM.Formal analysis: MA AT AOU DBB.Funding acquisition: AM NG AOU.Investigation: MA EES HL AT AOU DBB AM SB KM.Methodology: MA AT TH DBB AM SB KM.Project administration: MA DBB AT AM.Resources: AM NG DBB TH.Software: DBB TH.Supervision: DBB TH NG AM.Validation: EES HL.Visualization: EES HL AM DBB AN TH AT NG.Writing – original draft: MA EES HL AT AOU SB KM TH NG DBB AM.Writing – review & editing: MA EES HL AT AOU SB KM TH NG DBB AM. |
| ORCID | 0000-0001-8396-1031 |
| OpenAccessLink | https://doaj.org/article/abc60295faff4cd08c04b420e952d448 |
| PMID | 28406934 |
| PQID | 1887374554 |
| PQPubID | 1436336 |
| PageCount | e0175424 |
| ParticipantIDs | plos_journals_1887374554 doaj_primary_oai_doaj_org_article_abc60295faff4cd08c04b420e952d448 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5391020 proquest_miscellaneous_1888681106 proquest_journals_1887374554 gale_infotracmisc_A489519690 gale_infotracacademiconefile_A489519690 gale_incontextgauss_ISR_A489519690 gale_incontextgauss_IOV_A489519690 gale_healthsolutions_A489519690 pubmed_primary_28406934 crossref_primary_10_1371_journal_pone_0175424 crossref_citationtrail_10_1371_journal_pone_0175424 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2017-04-13 |
| PublicationDateYYYYMMDD | 2017-04-13 |
| PublicationDate_xml | – month: 04 year: 2017 text: 2017-04-13 day: 13 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2017 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | HM Lee (ref5) 2015; 8 JR Adams (ref37) 2005; 128 IG Zubal (ref25) 2007; 48 J Trinh (ref14) 2014; 71 D Aarsland (ref7) 2009; 72 D Berg (ref41) 2015; 30 W Meissner (ref6) 2012; 168 ref38 JM Fearnley (ref3) 1991; 114 J Infante (ref9) 2006; 395 C Spanaki (ref11) 2006; 67 JL Eriksen (ref2) 2005; 62 S Ben Sassi (ref12) 2012; 18 I Gayed (ref20) 2015; 40 ref24 SM Smith (ref35) 2004; 23 AJ Stoessl (ref19) 2014; 20 K Stiasny-Kolster (ref33) 2007; 22 ref22 DJ Brooks (ref15) 2010; 51 PK Morrish (ref21) 1995; 59 A Thaler (ref10) 2009; 116 S Fahn (ref29) 1987 ZS Nasreddine (ref30) 2005; 53 BS Connolly (ref8) 2014; 311 LJ Ozelius (ref27) 2006; 354 (ref4) 2003; 18 A Kas (ref39) 2007; 48 K Marder (ref13) 2015; 85 A Thaler (ref17) 2014; 29 M Sierra (ref44) 2011; 26 LM de Lau (ref1) 2004; 63 P Hagell (ref32) 2007; 16 P Schwingenschuh (ref40) 2010; 25 J Kachergus (ref28) 2005; 76 S Goldwurm (ref42) 2005; 42 N Pyatigorskaya (ref16) 2013 M Sierra (ref36) 2013; 80 S Goldwurm (ref43) 2011; 26 K Reetz (ref18) 2010; 39 AJ Hughes (ref26) 1992; 55 M Visser (ref31) 2004; 19 A Bergareche (ref23) 2016; 31 KR Chaudhuri (ref34) 2006; 21 J Trinh (ref45) 2014; 71 |
| References_xml | – volume: 48 start-page: 857 issue: 6 year: 2007 ident: ref25 article-title: Optimized, automated striatal uptake analysis applied to SPECT brain scans of Parkinson's disease patients publication-title: J Nucl Med doi: 10.2967/jnumed.106.037432 – volume: 67 start-page: 1518 issue: 8 year: 2006 ident: ref11 article-title: LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP publication-title: Neurology doi: 10.1212/01.wnl.0000239829.33936.73 – volume: 42 start-page: e65 issue: 11 year: 2005 ident: ref42 article-title: The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor publication-title: J Med Genet doi: 10.1136/jmg.2005.035568 – volume: 18 start-page: 738 issue: 7 year: 2003 ident: ref4 article-title: The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations publication-title: Movement disorders: official journal of the Movement Disorder Society doi: 10.1002/mds.10473 – volume: 21 start-page: 916 issue: 7 year: 2006 ident: ref34 article-title: International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study publication-title: Movement Disorders doi: 10.1002/mds.20844 – volume: 80 start-page: 621 issue: 7 year: 2013 ident: ref36 article-title: Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease publication-title: Neurology doi: 10.1212/WNL.0b013e31828250d6 – volume: 51 start-page: 596 issue: 4 year: 2010 ident: ref15 article-title: Imaging approaches to Parkinson disease publication-title: J Nucl Med doi: 10.2967/jnumed.108.059998 – volume: 55 start-page: 181 issue: 3 year: 1992 ident: ref26 article-title: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.55.3.181 – year: 2013 ident: ref16 article-title: A review of the use of magnetic resonance imaging in Parkinson’s disease publication-title: Therapeutic advances in neurological disorders – year: 1987 ident: ref29 article-title: Unified Parkinsons Disease Rating Scale – ident: ref38 doi: 10.1007/978-3-319-00846-2_110 – ident: ref22 – volume: 53 start-page: 695 issue: 4 year: 2005 ident: ref30 article-title: The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment publication-title: Journal of the American Geriatrics Society doi: 10.1111/j.1532-5415.2005.53221.x – volume: 71 start-page: 1535 issue: 12 year: 2014 ident: ref45 article-title: Disease penetrance of late-onset parkinsonism: a meta-analysis publication-title: JAMA neurology doi: 10.1001/jamaneurol.2014.1909 – volume: 18 start-page: 243 issue: 3 year: 2012 ident: ref12 article-title: Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease publication-title: Parkinsonism Relat Disord doi: 10.1016/j.parkreldis.2011.10.009 – volume: 85 start-page: 89 issue: 1 year: 2015 ident: ref13 article-title: Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium publication-title: Neurology doi: 10.1212/WNL.0000000000001708 – volume: 63 start-page: 1240 issue: 7 year: 2004 ident: ref1 article-title: Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study publication-title: Neurology doi: 10.1212/01.WNL.0000140706.52798.BE – volume: 311 start-page: 1670 issue: 16 year: 2014 ident: ref8 article-title: Pharmacological treatment of Parkinson disease: a review publication-title: JAMA doi: 10.1001/jama.2014.3654 – volume: 59 start-page: 597 issue: 6 year: 1995 ident: ref21 article-title: Clinical and [18F] dopa PET findings in early Parkinson's disease publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.59.6.597 – volume: 168 start-page: 809 issue: 11 year: 2012 ident: ref6 article-title: When does Parkinson's disease begin? From prodromal disease to motor signs publication-title: Revue neurologique doi: 10.1016/j.neurol.2012.07.004 – volume: 72 start-page: 1121 issue: 13 year: 2009 ident: ref7 article-title: Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study publication-title: Neurology doi: 10.1212/01.wnl.0000338632.00552.cb – volume: 71 start-page: 1535 issue: 12 year: 2014 ident: ref14 article-title: Disease penetrance of late-onset parkinsonism: a meta-analysis publication-title: JAMA neurology doi: 10.1001/jamaneurol.2014.1909 – volume: 395 start-page: 224 issue: 3 year: 2006 ident: ref9 article-title: LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease publication-title: Neurosci Lett doi: 10.1016/j.neulet.2005.10.083 – volume: 25 start-page: 560 issue: 5 year: 2010 ident: ref40 article-title: Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study publication-title: Movement disorders doi: 10.1002/mds.23019 – volume: 20 start-page: S180 issue: Suppl 1 year: 2014 ident: ref19 article-title: Developments in neuroimaging: positron emission tomography publication-title: Parkinsonism Relat Disord doi: 10.1016/S1353-8020(13)70042-7 – ident: ref24 doi: 10.1007/978-3-319-00846-2_110 – volume: 23 start-page: S208 issue: Suppl 1 year: 2004 ident: ref35 article-title: Advances in functional and structural MR image analysis and implementation as FSL publication-title: Neuroimage doi: 10.1016/j.neuroimage.2004.07.051 – volume: 26 start-page: 2144 issue: 11 year: 2011 ident: ref43 article-title: Kin-cohort analysis of LRRK2-G2019S penetrance in Parkinson's disease publication-title: Movement disorders: official journal of the Movement Disorder Society doi: 10.1002/mds.23807 – volume: 40 start-page: 390 issue: 5 year: 2015 ident: ref20 article-title: The impact of DaTscan in the diagnosis of Parkinson disease publication-title: Clinical nuclear medicine doi: 10.1097/RLU.0000000000000766 – volume: 354 start-page: 424 issue: 4 year: 2006 ident: ref27 article-title: LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews publication-title: The New England journal of medicine doi: 10.1056/NEJMc055509 – volume: 26 start-page: 2343 issue: 13 year: 2011 ident: ref44 article-title: High frequency and reduced penetrance of LRRK2 G2019S mutation among Parkinson's disease patients in Cantabria (Spain) publication-title: Movement disorders: official journal of the Movement Disorder Society doi: 10.1002/mds.23965 – volume: 114 start-page: 2283 issue: Pt 5 year: 1991 ident: ref3 article-title: Ageing and Parkinson's disease: substantia nigra regional selectivity publication-title: Brain: a journal of neurology doi: 10.1093/brain/114.5.2283 – volume: 19 start-page: 1306 issue: 11 year: 2004 ident: ref31 article-title: Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA-AUT publication-title: Movement Disorders doi: 10.1002/mds.20153 – volume: 22 start-page: 2386 issue: 16 year: 2007 ident: ref33 article-title: The REM sleep behavior disorder screening questionnaire—a new diagnostic instrument publication-title: Movement disorders doi: 10.1002/mds.21740 – volume: 31 start-page: 335 issue: 3 year: 2016 ident: ref23 article-title: DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease publication-title: Movement Disorders doi: 10.1002/mds.26478 – volume: 16 start-page: 102 issue: 1 year: 2007 ident: ref32 article-title: Measurement properties and hierarchical item structure of the Epworth Sleepiness Scale in Parkinson's disease publication-title: Journal of sleep research doi: 10.1111/j.1365-2869.2007.00570.x – volume: 8 start-page: 92 issue: 2 year: 2015 ident: ref5 article-title: Many Faces of Parkinson's Disease: Non-Motor Symptoms of Parkinson's Disease publication-title: Journal of movement disorders doi: 10.14802/jmd.15003 – volume: 62 start-page: 353 issue: 3 year: 2005 ident: ref2 article-title: Molecular pathogenesis of Parkinson disease publication-title: Arch Neurol doi: 10.1001/archneur.62.3.353 – volume: 76 start-page: 672 issue: 4 year: 2005 ident: ref28 article-title: Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations publication-title: American journal of human genetics doi: 10.1086/429256 – volume: 128 start-page: 2777 issue: 12 year: 2005 ident: ref37 article-title: PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation publication-title: Brain: a journal of neurology doi: 10.1093/brain/awh607 – volume: 116 start-page: 1473 issue: 11 year: 2009 ident: ref10 article-title: The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews publication-title: J Neural Transm doi: 10.1007/s00702-009-0303-0 – volume: 48 start-page: 1459 issue: 9 year: 2007 ident: ref39 article-title: Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images publication-title: J Nucl Med doi: 10.2967/jnumed.106.038646 – volume: 29 start-page: 823 issue: 6 year: 2014 ident: ref17 article-title: A voxel-based morphometry and diffusion tensor imaging analysis of asymptomatic Parkinson's disease-related G2019S LRRK2 mutation carriers publication-title: Movement disorders: official journal of the Movement Disorder Society doi: 10.1002/mds.25827 – volume: 39 start-page: 402 issue: 3 year: 2010 ident: ref18 article-title: Structural imaging in the presymptomatic stage of genetically determined parkinsonism publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2010.05.006 – volume: 30 start-page: 1600 issue: 12 year: 2015 ident: ref41 article-title: MDS research criteria for prodromal Parkinson's disease publication-title: Movement Disorders doi: 10.1002/mds.26431 |
| SSID | ssj0053866 |
| Score | 2.344668 |
| Snippet | Identification of early changes in Dopamine-Transporter (DaT) SPECT imaging expected in the prodromal phase of Parkinson's disease (PD), are usually... Identification of early changes in Dopamine-Transporter (DaT) SPECT imaging expected in the prodromal phase of Parkinson’s disease (PD), are usually... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0175424 |
| SubjectTerms | Adult Age Aged Asymmetry Audio frequencies Autonomic nervous system Basal ganglia Bioengineering Biological computing Biology and Life Sciences Biomarkers Brain Brain mapping Brain research Care and treatment Carriers Caudate-putamen Change detection Cognitive ability Cohort Studies Compensation Computer programs Diagnosis Documents Dopamine Dopamine - metabolism Dopamine receptors Dopamine transporter Dosage and administration Electrophysiological recording Engineering Environmental factors Gene mapping Gene mutation Genetic aspects Genetics Geriatrics Health aspects Health risks Humans Identification methods Incidence Inclusions Israel Jews Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 - genetics Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 - metabolism Magnetic resonance imaging Mathematical analysis Medicine Medicine and Health Sciences Middle Aged Movement disorders Mutation Mutation, Missense Neostriatum Nervous system Neurodegenerative diseases Neuroimaging Neurology Neurons Neurosciences Nuclear medicine Olfaction Parkinson disease Parkinson Disease - diagnostic imaging Parkinson Disease - genetics Parkinson Disease - metabolism Parkinson's disease Physical Sciences Positron emission tomography Psychology Research and Analysis Methods Risk factors Single photon emission computed tomography Single Photon Emission Computed Tomography Computed Tomography Skull Sleep Tracers Ventral Striatum - diagnostic imaging Ventral Striatum - metabolism Visual perception |
| SummonAdditionalLinks | – databaseName: DOAJ Open Access Full Text dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyquhBQxCAg5pk9hx7GMpLeWNdreot8hPqNRNoiZ74N8zTrxRgyqVA1f7c5TMwzOj2N8g9DJNFbW6ELEzlMRUcRVziCyxzZgsjICYbv3d4S9f2ckp_XiWn11p9eXPhA30wIPg9qXSLMlE7qRzVJuE64QqmiVW5JmB2sLvvhDzNsXUsAeDFzMWLsqRIt0Petlr6srugQ3mNKOTQNTz9Y-78qy5qNvrUs6_T05eCUXHd9GdkEPig-Hdt9AtW91DW8FLW_w6UEm_uY_kO7mMF9-PDpdYjhSc2NjmXHctNlAwryDL9AOeg7uucN97CLC_V01X92yu-D0Eb7HAn-fzTxlerYdf91jLS9_rrn2ATo-PlocncWiqEGsmsi5WxgmSu5RrygynOpNaCqucoIpJIn1LMs1TSxVIN4GhXDArpbSJIKkzjpOHaFaBGLcRZs4oqC-tNoWiSsDjU14URuVCW8GZjBDZSLjUgXHcN764KPvfaAVUHoPASq-XMuglQvG4qhkYN27Av_XKG7GeL7sfACsqgxWVN1lRhJ551ZfD5dPR68sDysFc4dOSCL3oEZ4zo_KHcn7KdduWH779-AfQYj4BvQogV4M4tAwXIeCbPBfXBLk7QYLn68n0tjfUjVTaMoWIQQoKGSKs3Bjv9dPPx2n_UH_QrrL1usdwxiEnZBF6NNj6KFnIZBImCKwuJl4wEf10pjr_1VOW5wTS0ix5_D90tYNuZz638oSbZBfNusu1fQKZYaee9pvAH1LdYuk priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLagSGgvaCuXlQ0ICAl4yJaL49hPaIyNcRmgtkN9i3zLmLQmoWkf9u85J3EDQRPwah9b8bk7tr9DyPMwVNTqVPi5obFPFVc-h8ji24jJ1AiI6RbfDp9-Zidn9MMsmbkfbrW7Vrn2iY2jNqXGf-T7IVhDnFKIfq-rHz5WjcLTVVdC4ya5hdBleKUrnXUbLrBlxtxzuTgN95109qqysHugiQmNaC8cNaj9nW8eVJdlfV3i-ef9yd8C0vEmueMySe-gFf0WuWGLIbl96s7Kh2Sj821XQ7LlbLj2Xjqg6Vd3iXwrp_7k69Hh1JMdQKdnbHWhl7VnYDs9h5mwARG6y8JrKhMB7dW8WpYN1qv3DkK7mHifxuOPkTdftQf7npYLrIRX3yNnx0fTwxPflVzwNRPR0lcmF3GSh1xTZjjVkdRSWJULqpiMJRYs0zy0VEWGBtCUCGallDYQcZibnMf3yaAA9m4Tj-VGwe7TapMqqgRMH_I0NSoR2grO5IjEa85n2uGRY1mMy6w5ZEthX9IyMkN5ZU5eI-J3o6oWj-Mf9G9QqB0tomk3DeXiPHPGmUmlWRCJJJd5TrUJuA6oolFgRQLrpHxEnqBKZO3T1M4nZAeUgzLD0oIRedZQIKJGgVd2zuWqrrP3X779B9Fk3CN64YjyEtihpXsmAWtCpK4e5W6PEvyC7nVvowKvuVJnvywIRq6V-vrup103TorX8ApbrhoazjhkjGxEHrQ20HEW8pyAiRhGpz3r6LG-31NcfG8AzZMYktYoePj3z9ohGxHmVAi0Ge-SwXKxso8gI1yqx43Z_wQX-GGf priority: 102 providerName: ProQuest |
| Title | DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28406934 https://www.proquest.com/docview/1887374554 https://www.proquest.com/docview/1888681106 https://pubmed.ncbi.nlm.nih.gov/PMC5391020 https://doaj.org/article/abc60295faff4cd08c04b420e952d448 http://dx.doi.org/10.1371/journal.pone.0175424 |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxMxELba9MIFUV4NlLAgJOCw1T68fhwQakPS8mip8kC5rfzaUinZDdlEohd-O2Nns2JREHDxwf5saccznvHa_gahF2EosVGU-5nGsY8lkz4Dz-KbiAiqOfh0Y98On1-QszH-MEkmO2iTs7USYLl1a2fzSY0X06Pv327egsG_cVkbaLjpdDQvcnMEGpbgCO-iPfBN1JrqOa7PFcC63emljVp8EgVx9ZjuT6M0nJXj9K9X7tZ8WpTbwtLfb1f-4q76d9DtKs70jteKsY92TH4X7VeWXHqvKrrp1_eQeCdG_vCy1x15oqbp9LSZX6tl6WnYVM8gErUVlqe7yD2XnwiwN7P5snCMr94pOHg-9D4NBh8jb7ZaH-97SixsPrzyPhr3e6PumV8lXvAV4dHSlzrjcZKFTGGiGVaRUIIbmXEsiYiFTVumWGiwjDQOoCrhxAghTMDjMNMZix-gVg5iPEAeybSEPahRmkosOQwfMkq1TLgynBHRRvFGwqmqWMltcoxp6o7aKOxO1gJL7byk1by0kV_3mq9ZOf6CP7GTV2Mtp7arKBZXaWWiqZCKBBFPMpFlWOmAqQBLHAWGJ_CdmLXRUzv16fqBar0ypMeYgUrDpwVt9NwhLK9Gbi_uXIlVWabvP3_5B9Bw0AC9rEBZAeJQonosAd9k-boayMMGElYH1Wg-sIq6kUqZhuBVYoohioSeG-Xd3vysbraD2st4uSlWDsMIg7iRtNHDta7XkoVoJyA8ht60YQUN0Tdb8uuvjtY8iSF0jYJH_zm3j9GtyIZaln8zPkSt5WJlnkCguJQdtEsnFErWDW3ZP-2gvZPexeWg4369dNzaYMsfvZ_JXG5A |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGkWAviJXLCoMFBII9ZMvFcewHhMYurLQdqO1Q34JvGZPWJDStUP8Uv5HjJA0ETcDLXu1jKz4-19j-DkIvXFdgLUNmxwr7NhZU2BQ8i609wkPFwKdr83Z4cEpOzvCHSTBZQz9Wb2HMtcqVTSwMtUql-Ue-54I2-CEG7_c2-2abqlHmdHVVQqMUi55efoeULX_TPYT9fel5x0fjgxO7qipgS8K8uS1UzPwgdqnERFEsPS450yJmWBDuc1OTS1JXY-Ep7EBTwIjmnGtI_d1YxdSHeW-gm-B4HaNR4aRO8MB2EFI9z_NDd6-Sht0sTfQuSH6APdxwf0WVgNoXtLLLNL8q0P3zvuZvDvD4LrpTRa7WfilqG2hNJ210a1CdzbfRem1Ll220UdmM3HpdAVvv3EP8kI_t0aejg7HFa0BQS-nsQs5zS0H6PoWZTINBBE8Tq6iEBLTLaTZPC2xZ6z2EEmxk9YfDnmdNF-VFAkvymam8l99HZ9eyGQ9QKwH2biKLxEpAtqulCgUWDKZ3aRgqETCpGSW8g_wV5yNZ4Z-bMhyXUXGoF0IeVDIyMvsVVfvVQXY9KivxP_5B_85sak1r0LuLhnR2HlXGIOJCEsdjQczjGEvlUOlggT1HswDWiWkHbRuRiMqnsLUNivYxBeWBpTkd9LygMAgeibkidM4XeR51P37-D6LRsEH0qiKKU2CH5NWzDFiTQQZrUG41KMEOyUb3phHgFVfy6JfGwsiVUF_d_azuNpOaa3-JThcFDSUUIlTSQQ9LHag5C3GVQ5gPo8OGdjRY3-xJLr4WAOqBD0Gy5zz6-2dto9sn40E_6ndPe4_RumfiOQPy6W-h1ny20E8gGp2Lp4UJsNCX67Y5PwH9maCA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKIlW9IFoeXSg0IBBwSDeJHcc-IFT6oKUPqm6L9hb8SqnUTZbNrtD-NX4d48QbCKqAS6_x2FqPZ74Zr-1vEHoRhpIYlXA_0wT7RDLpM4gsvomoSDSHmG7s2-GjY7p3Tj4O4sEC-jF_C2OvVc4xsQJqXSj7H3kvBG_ACYHo18vctYiT7d13o2--rSBlT1rn5TRqEzkws--wfSvf7m_DWr-Mot2ds60931UY8BXl0cSXOuM4zkKmCNWMqEgowY3MOJFUYGHrcykWGiIjTQL4FHNqhBAm4DjMdMYwjHsL3U5wHFofSwbNZg9whFL3VA8nYc9ZxsaoyM0GeEFMItIKhVXFgCYudEZXRXld0vvn3c3fguHuXXTHZbHeZm12y2jB5Cto8cid06-gpQZXZyto2eFH6b12JNdv7iGxLc78_snO1pknGnJQT5vRpZqUnoat_BBGsh8sO3iRe1VVJJCdDUeTouKZ9T5AWsH73uHp6UHkDaf1pQJPibGtwlfeR-c3shgPUCcH9a4ij2Zaws7XKJ1IIjkMH7Ik0TLmynBGRRfhueZT5bjQbUmOq7Q64EtgT1QrMrXrlbr16iK_6TWquUD-If_eLmoja5m8qw_F-CJ1wJAKqWgQ8TgTWUaUDpgKiCRRYHgM8ySsi9atSaT1s9gGj9JNwsCRYGpBFz2vJCybR2794kJMyzLd__T5P4T6py2hV04oK0AdSrgnGjAnyxLWklxrSQImqVbzqjXguVbK9Jf3Qs-5UV_f_KxptoPaK4C5KaaVDKMMslXaRQ9rH2g0CzlWQDmG3knLO1qqb7fkl18rMvUYQ8IcBY_-_rPW0SKgTXq4f3zwGC1FNrWzfJ94DXUm46l5AonpRD6tEMBDX24acn4CaMmktg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=DaT-SPECT+assessment+depicts+dopamine+depletion+among+asymptomatic+G2019S+LRRK2+mutation+carriers&rft.jtitle=PloS+one&rft.au=Artzi%2C+Moran&rft.au=Even-Sapir%2C+Einat&rft.au=Lerman+Shacham%2C+Hedva&rft.au=Thaler%2C+Avner&rft.date=2017-04-13&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=12&rft.issue=4&rft.spage=e0175424&rft_id=info:doi/10.1371%2Fjournal.pone.0175424&rft.externalDBID=n%2Fa&rft.externalDocID=10_1371_journal_pone_0175424 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |